Moreover, ABCB1 or ABCG2 overexpression in cancer cells is often associated with multidrug resistance (MDR) and poor prognosis in patients with solid tumors [6,7,8,9] or hematologic cancers [10,11,12,13,14,15,16]. This evidence concerns the gene ABCG2 and cancer.